LAB.00016 Fecal Analysis Panels in the Diagnosis of Intestinal Disorders

This policy addresses comprehensive fecal analysis panels (multi-marker stool tests, e.g., GI Effects) used to evaluate digestion/absorption, inflammation, microbiome, and metabolic markers for diagnosing intestinal disorders. Anthem considers these tests investigational and not medically necessary for all indications; they are not covered, including for evaluation of intestinal dysbiosis, irritable bowel syndrome, malabsorption, or small intestinal bacterial overgrowth. There are no covered indications or FDA-labeled uses under this policy.

"Fecal analysis panels are consideredinvestigational and not medically necessaryfor all indications, including as a diagnostic test for the evaluation of intestinal dysbiosis, irritable bowel syndro..."

Sign up to see full coverage criteria, indications, and limitations.